EMP1 and colorectal carcinoma: Our mechanistic study showed that UTX loss promoted colorectal oncogenesis partially via transcriptionally repression of EMP1 and AUTS2. Experiments performed with mouse CRC model and human CRC organoids further suggested that UTX deficiency confers enhanced sensitivity to EZH2 inhibitor GSK126 in CRC.